Solasia Pharma KK 4597.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 11/25/22 JST
54.00UNCH (UNCH)
Volume
1,822,600
52 week range
47.00 - 134.00
Loading...
  • Open54.00
  • Day High55.00
  • Day Low54.00
  • Prev Close54.00
  • 52 Week High134.00
  • 52 Week High Date02/10/22
  • 52 Week Low47.00
  • 52 Week Low Date10/13/22

Key Stats

  • Market Cap64.98M
  • Shares Out167.82M
  • 10 Day Average Volume1.81M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-49.53

KEY STATS

  • Open54.00
  • Day High55.00
  • Day Low54.00
  • Prev Close54.00
  • 52 Week High134.00
  • 52 Week High Date02/10/22
  • 52 Week Low47.00
  • 52 Week Low Date10/13/22
  • Market Cap64.98M
  • Shares Out167.82M
  • 10 Day Average Volume1.81M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-49.53

RATIOS/PROFITABILITY

  • EPS (TTM)-9.50
  • P/E (TTM)-5.68
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Solasia Pharma KK

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The Company's main products include SP-01 Granisetron Transdermal Delivery System...
Yoshihiro Arai
President, Chief Executive Officer, Representative Director
Toshio Miyashita
Chief Financial Officer, Chief Director of Administration, Director
Address
3F, Shiodome Bldg., 1-2-20, Kaigan
Minato-ku, TKY
105-0011
Japan